Skip to main content
Clinical Trials/NL-OMON24228
NL-OMON24228
Not Yet Recruiting
N/A

Discovery of non-invasive biomarkers for immune-mediated liver diseases; AIH, DILI, NAFL and NASH.

Investigator initiated study, funded by the Vrije Universiteit, University Medical Center0 sites0 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
autoimmune hepatitis, drug-induced liver injury, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
Sponsor
Investigator initiated study, funded by the Vrije Universiteit, University Medical Center
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Investigator initiated study, funded by the Vrije Universiteit, University Medical Center

Eligibility Criteria

Inclusion Criteria

  • Indication for a biopsy for the diagnosis or monitoring of; AIH, DILI, NAFL or NASH
  • Eligible for liver biopsy

Exclusion Criteria

  • Contraindication for liver biopsy, determined by the clinician.
  • Current infectious disease.

Outcomes

Primary Outcomes

Not specified

Similar Trials